2016 / 01

Следующая статья
DOI: 10.24075/brsmu.2016-01-09

МЕТОД

Тканевая хемилюминесценция как метод оценки супероксид радикал-продуцирующей способности митохондрий

А. А. Джатдоева, А. М. Полимова, Е. В. Проскурнина, Ю. А. Владимиров
Информация об авторах

Кафедра медицинской биофизики, факультет фундаментальной медицины,
Московский государственный университет имени М. В. Ломоносова, Москва

Для корреспонденции: Джатдоева Айшат Абдрахмановна
Ломоносовский пр-т, д. 31, корп. 5, г. Москва, 119192; moc.liamg@jdtahsya

Информация о статье

Финансирование: работа выполнена при поддержке Российского научного фонда (грант № 14-15-00375).

Благодарности: авторы благодарят Алексея Гришина, студента кафедры физиологии МГУ имени М. В. Ломоносова, за помощь в подборе состава газовых смесей.

Статья получена: 01.10.2015 Статья принята к печати: 09.12.2015 Опубликовано online: 05.01.2017
|
  1. Holt IJ, Cooper JM, Morgan-Hughes JA, Harding AE: Deletions of muscle mitochondrial DNA. Lancet. 1988 Jun 25; 1 (8600): 1462.
  2. Di Donato S: Multisystem manifestations of mitochondrial disorders. Journal of neurology 2009 May; 256 (5): 693–710.
  3. Kaminskyy VO, Zhivotovsky B: Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014 Jul 1; 21 (1): 86–102.
  4. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nature chemical biology. 2005 Sep; 1 (4): 223–32.
  5. Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Archives of toxicology. 2013; 87 (7): 1157–80.
  6. Льюин Б. Клетки. 9-е изд. М.: БИНОМ. Лаборатория знаний; 2011. 896 с.
  7. Anderson G, Maes M. Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins. Mol Neurobiol. 2014; 49 (2): 771–83.
  8. Caldeira GL, Ferreira IL, Rego AC. Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. J Alzheimers Dis. 2013; 34 (1): 115–31.
  9. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29; 362 (6423): 801–9.
  10. Madeo J, Zubair A, Marianne F. A review on the role of quinones in renal disorders. Springerplus. 2013; 2 (1): 139.
  11. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circulation research. 2010; 107 (9): 1058–70.
  12. Chang JC, Liu KH, Li YC, Kou SJ, Wei YH, Chuang CS, et al. Functional recovery of human cells harbouring the mitochondrial DNA mutation MERRF A8344G via peptide-mediated mitochondrial delivery. Neurosignals. 2013; 21 (3–4): 160–73.
  13. Sadun AA, Carelli V. The role of mitochondria in health, ageing, and diseases affecting vision. Br J Ophthalmol. 2006 Jul; 90 (7): 809–10.
  14. Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, Abdel-All Z, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol. 2006; 32 (4): 359–73.
  15. Mahato B, Jash S, Adhya S. RNA-mediated restoration of mitochondrial function in cells harboring a Kearns Sayre Syndrome mutation. Mitochondrion. 2011; 11 (4): 564–74.
  16. Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, et al: Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet. 2004; 13 (21): 2625–32.
  17. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993; 90 (17): 7915–22.
  18. Elias RJ, McClements DJ, Decker EA. Antioxidant activity of cysteine, tryptophan, and methionine residues in continuous phase beta-lactoglobulin in oil-in-water emulsions. J Agric Food Chem. 2005; 53 (26): 10248–53.
  19. Ruberg M, France-Lanord V, Brugg B, Lambeng N, Michel PP, Anglade P, et al. [Neuronal death caused by apoptosis in Parkinson disease]. Revue neurologique. 1997; 153 (8–9): 499–508. French.
  20. Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, et al. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med. 2009; 46 (11): 1439–53.
  21. Belikova NA, Tyurina YY, Borisenko G, Tyurin V, Samhan Arias AK, Yanamala N, et al. Heterolytic reduction of fatty acid hydroperoxides by cytochrome c/cardiolipin complexes: antioxidant function in mitochondria. J Am Chem Soc. 2009; 131 (32): 11288–9.
  22. Vladimirov YA. Free radical lipid peroxidation in biomembranes: Mechanism, regulation, and biological consequences. In: Johnson JE, Jr., Walford R, Harman D, Miquel J, editors. Free Radicals, Aging, and Degenerative Diseases. New York: Allan R. Liss, Inc.; 1986. p.141–95.
  23. Vladimirov YA, Olenev VI, Suslova TB, Cheremisina ZP. Lipid peroxidation in mitochondrial membrane. Adv Lipid Res. 1980; (17): 173–249.
  24. Skulachev VP. Mitochondria in the programmed death phenomena; a principle of biology: "it is better to die than to be wrong". IUBMB Life. 2000; 49 (5): 365–73.
  25. Владимиров Ю. А, Проскурнина Е. В, Измайлов Д. Ю. Кинетическая хемилюминесценция как метод изучения реакций свободных радикалов. Биофизика. 2011; 56 (6): 1081–90.
  26. Полимова А. М, Хакимова Г. Р, Владимиров Г. К, Жидкова Т. В, Измайлов Д. Ю, Проскурнина Е. В, и др. Активированная хемилюминесценция как метод оценки радикалобразующей способности ткани мозга. Технологии живых систем. 2012; 9 (10): 3–12.
  27. Sasaki T, Iwamoto A, Tsuboi H, Watanabe Y. Development of real-time bioradiographic system for functional and metabolic imaging in living brain tissue. Brain research. 2006; 1077 (1): 161–9.
  28. Oosthuizen MM, Engelbrecht ME, Lambrechts H, Greyling D, Levy RD. The effect of pH on chemiluminescence of different probes exposed to superoxide and singlet oxygen generators. J Biolumin Chemilumin. 1997; 12 (6): 277–84.
  29. Ugrumov MV, Khaindrava VG, Kozina EA, Kucheryanu VG, Bocharov EV, Kryzhanovsky GN, et al. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice. Neuroscience. 2011; 181: 175–88.